711 filings
Page 23 of 36
8-K
q8mpv
13 Mar 19
KemPharm Provides Update on APADAZĀ® Formulary Adoption
7:38am
S-8
n9dhvk2o5lj6
1 Mar 19
Registration of securities for employees
5:28pm
424B5
zgib35w1m 88ee5tfgms
1 Mar 19
Prospectus supplement for primary offering
5:05pm
424B5
9837t nvmoqtox
1 Mar 19
Prospectus supplement for primary offering
5:03pm
8-K
p7mskmj6
28 Feb 19
KemPharm Reports Q4 and FY 2018 Results
12:00am
4
x2gslujh r4g0
20 Feb 19
KEMPHARM / Gordon K Johnson ownership change
4:26pm
SC 13G/A
6jftjcg3t42
14 Feb 19
Kempharm, Inc
1:08pm
SC 13G/A
gvm0f2sw 7nmov5feaq
11 Feb 19
Kempharm, Inc
5:03pm
4
6w2f77mgs522 bcgf9
8 Feb 19
KEMPHARM / Travis C Mickle ownership change
7:29pm
4
k6qjo73
8 Feb 19
KEMPHARM / Gordon K Johnson ownership change
7:28pm
4
9ljgjliq4xz
8 Feb 19
KEMPHARM / Sven Guenther ownership change
7:28pm
4
tzx7151q
8 Feb 19
KEMPHARM / Timothy J. Sangiovanni ownership change
5:36pm
4
4rtsjle1ebj42c9c
8 Feb 19
KEMPHARM / R. LaDuane Clifton ownership change
5:36pm
SC 13G/A
n2xx2uv
17 Jan 19
Kempharm, Inc
4:05pm
8-K
wz82d8j9hy2
7 Jan 19
Regulation FD Disclosure
9:18am
8-K
jqd28k
19 Dec 18
KemPharm Provides Corporate Update on Partnering Process for ADHD Prodrug Portfolio
7:36am
8-K
otkbw6r61kvrtb8lvg
6 Dec 18
Regulation FD Disclosure
9:24am
SC 13G/A
ql47y7aoga3i im85
21 Nov 18
Kempharm, Inc
2:36pm
8-K
nvo4orw6fw7 tqebaejb
20 Nov 18
Entry into a Material Definitive Agreement
5:17pm